XPO1 inhibitors represent a novel therapeutic option in Adult T-cell Leukemia, triggering p53-mediated caspase-dependent apoptosis.

ABSTRACT:

SUBMITTER: Boons E 

PROVIDER: S-EPMC7873181 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature